Would you like to participate ask a question join the surfers in our next episode?

S2E36-ILC2021-Wrap-Up-Big-Issues-Key-Takeaways-Remaining-Issues

Key opinion leaders Quentin Anstee, Mazen Noureddin and Ian Rowe join Stephen, Louise and Roger to discuss the major lessons and dangling questions from #ILC2021.

The group shares perspectives, insights and questions on four key topics: diagnostics (including both non-invasive technologies and AI/machine learning), drug development, patient populations and policy.Mixed in here you will find discussions on food insecurity, polygenic risk and multi-disciplinary medicine. A great session to hear if you are still organizing your takeaways and questions emerging from the Congress.

TOPICS: Akero Therapeutics, cirrhosis, Diabetes, EchoSens, efruxifermin, FIB-4, FibroScan, inventiva, lanifibranor, Madrigal, MRI-PDFF, NAFLD, NASH, non-invasive liver testing, Novo Nordisk, Obesity, Semaglutide, social policy, TrialDesign, resmetirom, food insecurity, canigliflozin, Janssen Pharma, LITMUS consortium, MRE,Real World Evidence

Surfing The NASH Tsunami is brought to you by HEP Dynamics
#HEPdynamics #SurfingNASH #podcast

Request Transcript of This Episode
Request Transcript
First
Last

NASH & Diabetes Podcast and NASH Tsunami Podcast